The widespread popularity of hormone therapy in the United States is a triumph of marketing over science and advertising over common sense. Drug companies and many health care providers view menopause as a disease to be treated.
The much-belated Kronos Early Estrogen Prevention Study (KEEPS) data have patently discredited two popular post-Women’s Health Initiative (WHI) theories (the “timing hypothesis” and the “bioidentical Hormone Therapy is better than synthetic Hormone Therapy” argument).
You would think that the medical establishment would rejoice and celebrate this historic public health achievement: science giving women and their health care providers information that we can use to guide our behavior in a way that dramatically improves our health and saves lives. But, in the case of the WHI, you’d be wrong.
We are thrilled that the National Breast Cancer Coalition (NBCC) recently honored the Network with its Grassroots Activism Award for our success in reducing the incidence of breast cancer! The Network’s longtime advocacy — including our members’ and supporters’ activism —challenged the widespread use of hormone therapy and led to this important accomplishment.